Details for New Drug Application (NDA): 017046
✉ Email this page to a colleague
NDA 017046 describes KAON CL-10, which is a drug marketed by Savage Labs and is included in one NDA. Additional details are available on the KAON CL-10 profile page.
The generic ingredient in KAON CL-10 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
The generic ingredient in KAON CL-10 is potassium chloride. There are two hundred and forty drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the potassium chloride profile page.
Summary for 017046
| Tradename: | KAON CL-10 |
| Applicant: | Savage Labs |
| Ingredient: | potassium chloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 6.7MEQ | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MEQ | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
